Keyphrases
T Cells
100%
Kinase Activation
100%
Rapamycin
100%
Interleukin-2
100%
Cyclin A
85%
Cyclin E
71%
Cyclin-dependent Kinase
71%
G1 Phase
57%
Rapamycin Treatment
42%
Sigma Phase
28%
CTLL-2 Cells
28%
Inhibitory Effect
14%
Potent Inhibitor
14%
T Cell Lines
14%
Cell Cycle Control
14%
Cell Entry
14%
CTLL-2
14%
High-molecular-weight Complexes
14%
Histone H1
14%
Drug-treated
14%
Kinase Activity
14%
Biochemistry, Genetics and Molecular Biology
T Cell
100%
Interleukin 2
100%
Kinase
100%
Phosphotransferase
100%
Cyclin A
85%
Cyclin E
71%
G1 Phase
57%
Cyclin-Dependent Kinase
42%
S Phase
28%
Cyclin-Dependent Kinase Complex
28%
Cell Cycle Regulation
14%
Molecular Weight
14%
Histone H1
14%
Neuroscience
T Cell
100%
Kinase
100%
Interleukin 2
100%
Sirolimus
100%
Cyclin A
75%
Cyclin-Dependent Kinase
62%
Cyclin E
62%
Cell Cycle G1 Phase
50%
Cell Line
12%
Immunosuppressive Drug
12%
Cell Cycle Regulation
12%
Histone H1
12%
Immunosuppressant
12%
Immunology and Microbiology
T Cell
100%
Sirolimus
100%
Interleukin 2
100%
Cyclin A
75%
Cycline
62%
Cyclin E
62%
Cell Cycle G1 Phase
50%
Cell Line
12%
Immunosuppressive Drug
12%
Immunosuppressant
12%
Molecular Weight
12%
Cell Cycle Regulation
12%
Pharmacology, Toxicology and Pharmaceutical Science
Rapamycin
100%
Phosphotransferase
100%
Interleukin 2
100%
Cyclin A
75%
Cyclin Dependent Kinase
62%
Cyclin E
62%
Immunosuppressive Agent
12%
Histone H1
12%